Pharming Group NV
June 16, 2025
Company Presentation
Orphan and Rare Disease
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are commercializing and developing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
Company HQ City:
Leiden
Company HQ State:
South Holland
Company HQ Country:
Netherlands
Year Founded:
1988
Lead Product in Development:
Ruconest (constat alfa); Joenja (leniolisib)
CEO
CEO - Fabrice Chouraqui, MBA, PharmD
Development Phase of Lead Product
Multiple Products in Market
Exchange
NASDAQ
Ticker
PHAR
When you expect your next catalyst update?
Jeonja for APDS - VUSs, pediatric label, geo expansion; Leniolisib for PID Ph 2 readouts.
What is your next catalyst (value inflection) update?
2025 & 2026
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}